Phio Pharmaceuticals Corp. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 166.80 K | $62.00 K | -21.91% | 1.22% |
VANGUARD GROUP INC | 02/10/2023 | 154.54 K | $57.49 K | -29.17% | 1.13% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 106.92 K | $39.00 K | -0.26% | 0.78% |
CETERA INVESTMENT ADVISERS | 02/14/2023 | 75.00 K | $27.90 K | 0.00% | 0.55% |
UBS GROUP AG | 02/08/2023 | 23.03 K | $8.52 K | 100.00% | 0.17% |
TWO SIGMA INVESTMENTS, LP | 02/14/2023 | 22.40 K | $8.33 K | -3.45% | 0.16% |
TWO SIGMA SECURITIES, LLC | 02/14/2023 | 19.71 K | $7.33 K | -11.69% | 0.14% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 5.22 K | $2.00 K | -4.48% | 0.04% |
MORGAN STANLEY | 02/14/2023 | 1.50 K | $558 | -0.13% | 0.01% |
WELLS FARGO & COMPANY/MN | 02/13/2023 | 93 | $35 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 02/13/2023 | 50 | $0 | -94.25% | 0.00% |
BLACKROCK INC. | 02/13/2023 | 19 | $7 | 100.00% | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
HRT FINANCIAL LP | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
ERGOTELES LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
Phio Pharmaceuticals Corp. institutional Ownership - FAQ's
4.22% of Phio Pharmaceuticals Corp. stock is owned by institutional investors.